Protocol for <it>G</it>erman trial of <it>A</it>cyclovir and <it>c</it>orticosteroids in <it>H</it>erpes-simplex-virus-<it>e</it>ncephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]
<p>Abstract</p> <p>Background</p> <p>The treatment of Herpes-simplex-virus-encephalitis (HSVE) remains a major unsolved problem in Neurology. Current gold standard for therapy is acyclovir, a drug that inhibits viral replication. Despite antiviral treatment, mortality r...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | BMC Neurology |
Online Access: | http://www.biomedcentral.com/1471-2377/8/40 |